CASEY BADIK: Open Payments
NPI 1700305463 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 16 payments from 10 companies in 2025. Trend: 2023 $675 · 2024 $662 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Exact Sciences Corporation | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Novo Nordisk Inc | 2 | $31 |
| Sumitomo Pharma America, Inc. | 2 | $28 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
| ABBVIE INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $16 |
Products named: The Cologuard Plus Collection Kit, AIRSUPRA, TZIELD, VRAYLAR, JARDIANCE, OPSUMIT, AREXVY, Wegovy.
Industry payments across PA — which companies pay providers there.
